ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Green synthesized selenium nanoparticles mitigate cyclophosphamide-induced reproductive toxicity in male Wistar rats.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cyclophosphamide (CP), a widely used alkylating chemotherapeutic and immunosuppressive agent, is associated with significant reproductive toxicity in male patients, primarily through oxidative stress and inflammatory damage to testicular tissue. This study investigates the protective effect of green-synthesised selenium nanoparticles (SeNPs) from Azadirachta indica leaves extract against CP-induced reproductive toxicity in male Wistar rats. SeNPs were characterised by FTIR, XRD, DLS, SEM, TEM, and EDX, confirming crystalline structure, and mean particle sizes of 70-100 nm. Male rats (n = 30) were randomly divided into five groups consisting of six rats per group and treated with CP (15 mg/kg/week, i.p.) and/or SeNPs (0.2 mg/kg/day, oral) for 28 days. CP significantly reduced serum testosterone, LH, and FSH, impaired antioxidant enzymes, and disrupted sperm parameters and testicular histology (p < 0.05). Co-treatment with SeNPs significantly restored serum testosterone, LH, and FSH levels. Additionally, SeNP has reduced IL-1β and TNF-α levels compared to the CP group. Results suggest SeNPs may mitigate CP-induced reproductive toxicity via antioxidant and anti-inflammatory mechanisms.
Indexed as
Identifiers
41452359What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.